Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
出版年份 2015 全文链接
标题
Anti-Diabetes Drug Pioglitazone Ameliorates Synaptic Defects in AD Transgenic Mice by Inhibiting Cyclin-Dependent Kinase5 Activity
作者
关键词
Mouse models, Alzheimers disease, Neuronal dendrites, Neurons, Drug therapy, Cognitive impairment, Kinase inhibitors, Pathogenesis
出版物
PLoS One
Volume 10, Issue 4, Pages e0123864
出版商
Public Library of Science (PLoS)
发表日期
2015-04-16
DOI
10.1371/journal.pone.0123864
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Troglitazone, a thiazolidinedione, decreases tau phosphorylation through the inhibition of cyclin-dependent kinase 5 activity in SH-SY5Y neuroblastoma cells and primary neurons
- (2013) Du-Hyong Cho et al. JOURNAL OF NEUROCHEMISTRY
- Intranasal administration of nerve growth factor ameliorate β-amyloid deposition after traumatic brain injury in rats
- (2012) Lili Tian et al. BRAIN RESEARCH
- A truncated peptide from p35, a Cdk5 activator, prevents Alzheimer's disease phenotypes in model mice
- (2012) Varsha Shukla et al. FASEB JOURNAL
- PPARγagonist pioglitazone improves scopolamine-induced memory impairment in mice
- (2012) Guo Qing Xiang et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease
- (2012) Rachna Gupta et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- S-nitrosylation of Cdk5
- (2012) Jing Qu et al. Prion
- Effects of long-term treatment with pioglitazone on cognition and glucose metabolism of PS1-KI, 3xTg-AD and wild-type mice
- (2012) F Masciopinto et al. Cell Death & Disease
- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk
- (2012) Giuseppe Derosa et al. Current Molecular Pharmacology
- Rosiglitazone and Pioglitazone for the Treatment of Alzheimer's Disease
- (2011) Benjamin W Miller et al. ANNALS OF PHARMACOTHERAPY
- Cyclin-Dependent Kinases in Brain Development and Disease
- (2011) Susan C. Su et al. Annual Review of Cell and Developmental Biology
- Cdk5-mediated phosphorylation of endophilin B1 is required for induced autophagy in models of Parkinson's disease
- (2011) Alan S. L. Wong et al. NATURE CELL BIOLOGY
- S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by -amyloid peptide
- (2011) J. Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cdk5: a multifaceted kinase in neurodegenerative diseases
- (2011) Zelda H. Cheung et al. TRENDS IN CELL BIOLOGY
- A 24-Residue Peptide (p5), Derived from p35, the Cdk5 Neuronal Activator, Specifically Inhibits Cdk5-p25 Hyperactivity and Tau Hyperphosphorylation
- (2010) Ya-Li Zheng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARγ by Cdk5
- (2010) Jang Hyun Choi et al. NATURE
- Early Alzheimer's Disease
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Alzheimer's Disease
- (2010) Henry W. Querfurth et al. NEW ENGLAND JOURNAL OF MEDICINE
- Delayed Treatment with Systemic (S)-Roscovitine Provides Neuroprotection and Inhibits In Vivo CDK5 Activity Increase in Animal Stroke Models
- (2010) Bénédicte Menn et al. PLoS One
- Recent advances in understanding the roles of Cdk5 in synaptic plasticity
- (2009) Kwok-On Lai et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD
- (2009) Masashi Kitazawa et al. JOURNAL OF NEUROCHEMISTRY
- c-Abl tyrosine kinase modulates tau pathology and Cdk5 phosphorylation in AD transgenic mice
- (2009) Gonzalo I. Cancino et al. NEUROBIOLOGY OF AGING
- The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes
- (2009) V. Lalioti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer's disease
- (2008) Wei-Qin Zhao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Peroxisome Proliferator-Activated Receptor Pathway Targeting in Carcinogenesis: Implications for Chemoprevention
- (2008) F. Ondrey CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started